In Fgl2−/− mice, ovarian tumors displayed enhanced infiltration of cDC1s, CD3+ T cells, and DNAM-1+ NK cells, and they induced expression of co-stimulatory markers (MHC-II, CD86+, and CD40+) in spleen, resulting in reduced tumor burden. The gene discussed is CD86; the disease is neoplasm.